PharmaCord LLC, has been recognized as a Bronze COVID Stops Here workplace for achieving a 70% vaccination rate.
The COVID Stops Here campaign recognizes Kentucky workplaces that have achieved widespread vaccination against COVID-19. Organizations that have achieved at least a 70% vaccination rate are eligible to receive a designation.
It is critical that Kentuckians work together to stop the spread of coronavirus — including the dangerous new Delta variant. Vaccination is the best way to stop COVID-19.
At PharmaCord, we’re very proud that our business values have always included a ‘People First, Patient First’ mentality. We’re proud to be a COVID-19 employer and are taking extraordinary precautions to ensure the safety of our team members while simultaneously assuring that we continue to serve the patients and clients who count on us each day,” said PharmaCord Associate Director of Human Resources, Staci McArter Galloway.
The Kentucky Chamber of Commerce developed the COVID Stops Here campaign as a way to celebrate workplaces that are leading the fight to stop COVID-19 — and to encourage more organizations to join their ranks.
“The COVID-19 vaccine is Kentucky’s pathway to recovery. PharmaCord is helping set the bar for vaccination in Kentucky by achieving Bronze COVID Stops Here status — meaning at least 70% of their employees are now vaccinated against COVID-19. This is a great achievement and we thank them for helping our state stop this dangerous virus,” said Kentucky Chamber President and CEO Ashli Watts. “Employers are playing a very important as we work to encourage vaccination in Kentucky. In order to finally put this virus behind us, we need Kentuckians to get vaccinated as soon as possible. Together we can stop this virus, let’s make sure that COVID stops here!”
Learn more at kychamber.com/CovidStopsHere
PharmaCord is the connector between manufacturers, patients, physicians, and payers. The company provides customized solutions to life sciences companies that span three core areas: patient support, pharmacy services and manufacturer support. These integrated services are designed to increase accessibility, clinical oversight and market acceptance of prescription therapy. Independently owned and organically built, PharmaCord is free from any competing priorities, enabling it to design and implement patient access and support programs that align with the objectives of its life sciences clients. PharmaCord’s experienced team coupled with its proprietary CORscend™ technology platform optimizes workflow to deliver improved program execution, more rapid therapy initiation and increased patient engagement. To learn more about how PharmaCord improves commercial outcomes for life sciences companies, visit pharmacord.com.